Olema Pharmaceuticals, Inc.·4

Feb 5, 5:30 PM ET

Kovacs Shane William Charles 4

4 · Olema Pharmaceuticals, Inc. · Filed Feb 5, 2024

Insider Transaction Report

Form 4
Period: 2024-02-01
Kovacs Shane William Charles
CH. OPERATING & FINANCIAL OFF.
Transactions
  • Award

    Stock Option (Right to Buy)

    2024-02-01+304,500304,500 total
    Exercise: $15.25Exp: 2034-01-31Common Stock (304,500 underlying)
Footnotes (1)
  • [F1]25% of the shares subject to the option vest on February 1, 2025 and 1/48 of the total number of shares subject to the option vest each month thereafter, subject to the Reporting Person's continuous service through each applicable vesting date.

Documents

1 file
  • 4
    form4-02052024_050206.xmlPrimary